Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2005. Start Trial.
Date Value
June 30, 2026 27.39%
March 31, 2026 28.35%
December 31, 2025 22.92%
September 30, 2025 21.70%
June 30, 2025 23.08%
March 31, 2025 31.33%
December 31, 2024 34.79%
September 30, 2024 33.68%
June 30, 2024 34.20%
March 31, 2024 33.10%
December 31, 2023 33.48%
September 30, 2023 24.02%
June 30, 2023 31.36%
March 31, 2023 14.57%
December 31, 2022 28.03%
September 30, 2022 12.36%
June 30, 2022 18.37%
March 31, 2022 28.19%
December 31, 2021 26.71%
September 30, 2021 26.92%
June 30, 2021 27.40%
March 31, 2021 34.22%
December 31, 2020 28.78%
September 30, 2020 44.85%
June 30, 2020 40.49%
Date Value
March 31, 2020 40.79%
December 31, 2019 40.34%
September 30, 2019 43.81%
June 30, 2019 49.20%
March 31, 2019 45.55%
December 31, 2018 36.45%
September 30, 2018 34.67%
June 30, 2018 34.44%
March 31, 2018 40.72%
December 31, 2017 44.37%
September 30, 2017 44.54%
June 30, 2017 44.34%
March 31, 2017 43.24%
December 31, 2016 44.47%
September 30, 2016 48.36%
June 30, 2016 45.77%
March 31, 2016 45.04%
December 31, 2015 45.06%
September 30, 2015 32.35%
June 30, 2015 18.70%
March 31, 2015 -70.86%
December 31, 2014 11.17%
September 30, 2014 11.45%
June 30, 2014 13.30%
March 31, 2014 13.88%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Chemed Corp. 30.37%
The Ensign Group, Inc. 14.47%
National HealthCare Corp. 73.30%
Oncologix Tech, Inc. --
InnovAge Holding Corp. 21.46%

Gross Profit Margin (Quarterly) Related Metrics